This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1s63

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 20: Line 20:
==About this Structure==
==About this Structure==
-
1S63 is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S63 OCA].
+
1S63 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S63 OCA].
==Reference==
==Reference==
-
Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes., Reid TS, Long SB, Beese LS, Biochemistry. 2004 Jul 20;43(28):9000-8. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15248757 15248757]
+
<ref group="xtra">PMID:15248757</ref><references group="xtra"/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Protein complex]]
 
[[Category: Protein farnesyltransferase]]
[[Category: Protein farnesyltransferase]]
[[Category: Beese, L S.]]
[[Category: Beese, L S.]]
Line 41: Line 40:
[[Category: Ra]]
[[Category: Ra]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 15:41:43 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 13:17:54 2009''

Revision as of 11:17, 16 February 2009

Template:STRUCTURE 1s63

Human protein farnesyltransferase complexed with L-778,123 and FPP

Template:ABSTRACT PUBMED 15248757

About this Structure

1S63 is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Reid TS, Long SB, Beese LS. Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes. Biochemistry. 2004 Jul 20;43(28):9000-8. PMID:15248757 doi:10.1021/bi049280b

Page seeded by OCA on Mon Feb 16 13:17:54 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools